Incyte (INCY) /AstraZeneca (AZN) Collaboration Could Lead to Upside - Oppenheimer
Tweet Send to a Friend
Incyte (NASDAQ: INCY) announced a collaboration with AstraZeneca (NYSE: AZN) to evaluate INCB39110 (JAK1 inhibitor) in combination with Tagrisso ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
